<VariationArchive VariationID="2436163" VariationName="NM_000135.4(FANCA):c.50dup (p.Arg18fs)" VariationType="Duplication" Accession="VCV002436163" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-17" DateCreated="2023-03-05" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2408783" VariationID="2436163">
      <GeneList>
        <Gene Symbol="FANCA" FullName="FA complementation group A" GeneID="2175" HGNC_ID="HGNC:3582" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89737549" stop="89816647" display_start="89737549" display_stop="89816647" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89803958" stop="89883064" display_start="89803958" display_stop="89883064" Strand="-" />
          </Location>
          <OMIM>607139</OMIM>
        </Gene>
        <Gene Symbol="LOC112486223" FullName="Sharpr-MPRA regulatory region 3988" GeneID="112486223" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89816431" stop="89816875" display_start="89816431" display_stop="89816875" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000135.4(FANCA):c.50dup (p.Arg18fs)</Name>
      <CanonicalSPDI>NC_000016.10:89816565:CCCCC:CCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89816565" stop="89816566" display_start="89816565" display_stop="89816566" variantLength="1" positionVCF="89816565" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89882973" stop="89882974" display_start="89882973" display_stop="89882974" variantLength="1" positionVCF="89882973" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>R18fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.89816570dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.89816570dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.89882978dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.89882978dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011706.1" sequenceAccession="NG_011706" sequenceVersion="1" change="g.5092dup">
            <Expression>NG_011706.1:g.5092dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_056867.1" sequenceAccession="NG_056867" sequenceVersion="1" change="g.90dup">
            <Expression>NG_056867.1:g.90dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000135.4" sequenceAccession="NM_000135" sequenceVersion="4" change="c.50dup" MANESelect="true">
            <Expression>NM_000135.4:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000126.2" sequenceAccession="NP_000126" sequenceVersion="2" change="p.Arg18fs">
            <Expression>NP_000126.2:p.Arg18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018112.3" sequenceAccession="NM_001018112" sequenceVersion="3" change="c.50dup">
            <Expression>NM_001018112.3:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018122.1" sequenceAccession="NP_001018122" sequenceVersion="1" change="p.Arg18fs">
            <Expression>NP_001018122.1:p.Arg18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286167.3" sequenceAccession="NM_001286167" sequenceVersion="3" change="c.50dup">
            <Expression>NM_001286167.3:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001273096.1" sequenceAccession="NP_001273096" sequenceVersion="1" change="p.Arg18fs">
            <Expression>NP_001273096.1:p.Arg18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351830.2" sequenceAccession="NM_001351830" sequenceVersion="2" change="c.50dup">
            <Expression>NM_001351830.2:c.50dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338759.1" sequenceAccession="NP_001338759" sequenceVersion="1" change="p.Arg18fs">
            <Expression>NP_001338759.1:p.Arg18fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_495" sequenceAccession="LRG_495">
            <Expression>LRG_495:g.5092dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_495t1" sequenceAccession="LRG_495t1">
            <Expression>LRG_495t1:c.46dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_495p1" sequenceAccession="LRG_495p1" change="p.Arg18Profs">
            <Expression>LRG_495p1:p.Arg18Profs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000135.4(FANCA):c.50dup (p.Arg18fs) AND Fanconi anemia complementation group A" Accession="RCV003136913" Version="3">
        <ClassifiedConditionList TraitSetID="883">
          <ClassifiedCondition DB="MedGen" ID="C3469521">Fanconi anemia complementation group A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-03-05" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="883" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9887" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group A</ElementValue>
                <XRef ID="MONDO:0009215" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fanconi anemia, group A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCA</ElementValue>
                <XRef Type="MIM" ID="227650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FANCA-Related Fanconi Anemia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15170" />
                <XRef ID="15170" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2008">
                <URL>http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf</URL>
                <CitationText>Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008 (See 2020 Update)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="FARF, 2020">
                <URL>https://www.fanconi.org/images/uploads/other/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.pdf</URL>
                <CitationText>Fanconi Anemia Clinical Care Guidelines, Fifth Edition.</CitationText>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3469521" DB="MedGen" />
              <XRef ID="MONDO:0009215" DB="MONDO" />
              <XRef Type="MIM" ID="227650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7129842" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="8f0995364772027ec44ff855c4e101ce3e2102c5616b322ce2173bdcfd2d9325|OMIM:227650" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003821937" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000135.4:c.50dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227650" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7129842" TraitType="Disease" MappingType="XRef" MappingValue="227650" MappingRef="OMIM">
        <MedGen CUI="C3469521" Name="Fanconi anemia complementation group A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

